Carter D. Brooks
About
In The Last Decade
Carter D. Brooks
26 papers receiving 420 citations
Peers
Comparison fields: 5 of 99
- Pharmacology 148
- Physiology 141
- Immunology and Allergy 118
- Pulmonary and Respiratory Medicine 56
- Molecular Biology 52
Countries citing papers authored by Carter D. Brooks
This map shows the geographic impact of Carter D. Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carter D. Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carter D. Brooks more than expected).
Fields of papers citing papers by Carter D. Brooks
This network shows the impact of papers produced by Carter D. Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carter D. Brooks. The network helps show where Carter D. Brooks may publish in the future.
Co-authorship network of co-authors of Carter D. Brooks
This figure shows the co-authorship network connecting the top 25 collaborators of Carter D. Brooks. A scholar is included among the top collaborators of Carter D. Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carter D. Brooks. Carter D. Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 60 | |
| 2 | 10 | |
| 3 | 15 | |
| 4 | Sulfasalazine for the management of juvenile rheumatoid arthritis. | 31 |
| 5 | 8 | |
| 6 | 2 | |
| 7 | 22 | |
| 8 | 32 | |
| 9 | 18 | |
| 10 | Effect of vasoconstrictor pre-treatment on obstruction, secretion and sneezing after nasal challenge with threshold and suprathreshold allergen doses. | 3 |
| 11 | 8 | |
| 12 | 24 | |
| 13 | 13 | |
| 14 | 1 | |
| 15 | 34 | |
| 16 | 2 | |
| 17 | 6 | |
| 18 | 23 | |
| 19 | 31 | |
| 20 | 11 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.